• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脾切除患者对结合型脑膜炎奈瑟菌 C 群疫苗的抗体应答受损。

Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients.

机构信息

Department of Internal Medicine, St Antonius Hospital Nieuwegein, PO Box 2500, 3430 EM, Nieuwegein, The Netherlands.

出版信息

Eur J Clin Microbiol Infect Dis. 2011 May;30(5):611-8. doi: 10.1007/s10096-010-1129-2. Epub 2010 Dec 24.

DOI:10.1007/s10096-010-1129-2
PMID:21184126
Abstract

The purpose of this study was to determine the quantity and quality of antibodies against the meningococcal serogroup C (MenC) conjugated vaccine in asplenic patients. In 116 asplenic patients, antibody concentrations (IgG) were measured against meningococcal serogroup C before and after immunisation. Of MenC-specific IgG, both antibody avidity and subclasses of IgG1 and IgG2 were determined. The mean MenC IgG concentration rose from 0.16 μg/mL prior to vaccination to 3.69 μg/mL 3 weeks post-vaccination, with 67% of patients reaching the threshold of ≥ 2.0 μg/mL. The mean IgG concentration at 35 weeks post-vaccination was 3.10 μg/mL. IgG2 concentrations increased more than IgG1. Marginal avidity maturation was seen. Hypo-responders to the first MenC vaccine (IgG anti-MenC ≤ 2.0 μg/mL) were offered a booster dose. After revaccination, 59% reached the chosen IgG threshold. The IgG concentration rose from 0.29 to 1.12 μg/mL, with an increase in the IgG1/IgG2 ratio. Avidity indices remained below 33%. In asplenic patients, the quantity and quality of antibodies produced after one dose of conjugated MenC vaccination is lower than that observed in previous studies in healthy adults. Booster vaccination does, indeed, lead to a rise in IgG geometric mean concentrations (GMCs), but does not lead to higher avidity of antibodies.

摘要

本研究旨在确定脾切除患者针对脑膜炎奈瑟菌 C 群(MenC)结合疫苗的抗体数量和质量。在 116 例脾切除患者中,在免疫接种前后测量了针对脑膜炎奈瑟菌 C 群的抗体浓度(IgG)。测定了 MenC 特异性 IgG 的抗体亲和力以及 IgG1 和 IgG2 的亚类。MenC 特异性 IgG 浓度从接种前的 0.16μg/mL 上升至接种后 3 周的 3.69μg/mL,其中 67%的患者达到≥2.0μg/mL 的阈值。接种后 35 周时的平均 IgG 浓度为 3.10μg/mL。IgG2 浓度的增加高于 IgG1。可见边缘亲和力成熟。对首次 MenC 疫苗(IgG 抗-MenC≤2.0μg/mL)无反应的患者给予加强剂量。加强免疫后,59%的患者达到选择的 IgG 阈值。IgG 浓度从 0.29μg/mL 上升至 1.12μg/mL,同时 IgG1/IgG2 比值增加。亲和力指数仍低于 33%。在脾切除患者中,一剂结合型 MenC 疫苗接种后产生的抗体数量和质量低于既往健康成年人研究中的观察结果。加强免疫确实会导致 IgG 几何平均浓度(GMC)升高,但不会导致抗体亲和力升高。

相似文献

1
Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients.脾切除患者对结合型脑膜炎奈瑟菌 C 群疫苗的抗体应答受损。
Eur J Clin Microbiol Infect Dis. 2011 May;30(5):611-8. doi: 10.1007/s10096-010-1129-2. Epub 2010 Dec 24.
2
Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.单价C群脑膜炎球菌疫苗与四价ACWY群脑膜炎球菌结合加强疫苗诱导的C群脑膜炎球菌免疫原性、抗体持久性及记忆B细胞:一项随机对照试验
Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28.
3
Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.初免九年后青少年对C群脑膜炎球菌结合疫苗加强免疫的唾液抗体水平:全身诱导的局部免疫及唾液作为潜在监测工具
Vaccine. 2015 Jul 31;33(32):3933-9. doi: 10.1016/j.vaccine.2015.06.055. Epub 2015 Jun 19.
4
Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.荷兰青少年接种单价脑膜炎奈瑟菌 C 群或四价脑膜炎奈瑟菌 A、C、W 和 Y 群结合疫苗后唾液抗体水平的诱导。
PLoS One. 2018 Apr 19;13(4):e0191261. doi: 10.1371/journal.pone.0191261. eCollection 2018.
5
Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.加强免疫 Hib-MenC-TT 结合疫苗后抗体反应的持久性:一项随访研究。
Pediatr Infect Dis J. 2012 Oct;31(10):1069-73. doi: 10.1097/INF.0b013e318262528c.
6
Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.青少年先前已接种结合疫苗,之后接种 C 群脑膜炎奈瑟球菌糖缀合物或多糖疫苗加强针后,1 年时血清杀菌抗体的持续存在。
Pediatr Infect Dis J. 2011 Nov;30(11):e203-8. doi: 10.1097/INF.0b013e318224fb14.
7
Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.荷兰青少年接种脑膜炎球菌C群破伤风加强疫苗后保护性抗体的长期持久性。
Vaccine. 2016 Dec 7;34(50):6309-6315. doi: 10.1016/j.vaccine.2016.10.049. Epub 2016 Nov 4.
8
Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.用单价B群脑膜炎球菌外膜囊泡疫苗免疫后的抗体亲和力及免疫球蛋白G亚型分布
Infect Immun. 2002 Feb;70(2):584-90. doi: 10.1128/IAI.70.2.584-590.2002.
9
Age-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgG.年龄相关的脑膜炎球菌 C 群疫苗免疫:IgG2 的持久性增加与 IgG 的亲和力降低相关。
PLoS One. 2011;6(8):e23497. doi: 10.1371/journal.pone.0023497. Epub 2011 Aug 24.
10
Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults.成人初次接种脑膜炎球菌 C 群结合疫苗或再次接种结合疫苗或多糖疫苗后抗体反应的动力学。
Vaccine. 2009 Nov 23;27(50):6974-82. doi: 10.1016/j.vaccine.2009.09.082. Epub 2009 Oct 1.

引用本文的文献

1
Vaccinations in Pediatric Hematology and Oncology: Biologic Basis, Clinical Applications, and Perspectives.儿科血液学与肿瘤学中的疫苗接种:生物学基础、临床应用及展望
Vaccines (Basel). 2025 Apr 10;13(4):397. doi: 10.3390/vaccines13040397.
2
Asplenia and spleen hypofunction.脾缺失和脾功能低下。
Nat Rev Dis Primers. 2022 Nov 3;8(1):71. doi: 10.1038/s41572-022-00399-x.
3
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.脑膜炎球菌疫苗接种:美国免疫实践咨询委员会 2020 年的建议。

本文引用的文献

1
The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years.50至80岁成年人中7价肺炎球菌结合疫苗与23价多糖疫苗的免疫原性比较
Clin Infect Dis. 2009 Nov 1;49(9):1318-25. doi: 10.1086/606046.
2
Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults.成人初次接种脑膜炎球菌 C 群结合疫苗或再次接种结合疫苗或多糖疫苗后抗体反应的动力学。
Vaccine. 2009 Nov 23;27(50):6974-82. doi: 10.1016/j.vaccine.2009.09.082. Epub 2009 Oct 1.
3
MMWR Recomm Rep. 2020 Sep 25;69(9):1-41. doi: 10.15585/mmwr.rr6909a1.
4
[Not Available].[无可用内容]。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):588-644. doi: 10.1007/s00103-020-03123-w.
5
Persistent changes in circulating white blood cell populations after splenectomy.脾切除术后循环白细胞群体的持续变化。
Int J Hematol. 2018 Feb;107(2):157-165. doi: 10.1007/s12185-017-2335-9. Epub 2017 Sep 26.
6
Recommended vaccinations for asplenic and hyposplenic adult patients.无脾和脾功能减退成年患者的推荐疫苗接种。
Hum Vaccin Immunother. 2017 Feb;13(2):359-368. doi: 10.1080/21645515.2017.1264797.
7
Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases.恶性和非恶性血液系统疾病脾切除术后的细菌感染
Mediterr J Hematol Infect Dis. 2015 Oct 13;7(1):e2015057. doi: 10.4084/MJHID.2015.057. eCollection 2015.
8
Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.相对较高的血清维生素 D 水平不会损害对荚膜细菌的抗体反应。
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):61-9. doi: 10.1007/s10096-012-1714-7. Epub 2012 Aug 9.
Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.
基于荧光微球的多重免疫测定法同时检测b型流感嗜血杆菌多糖特异性抗体和A、C、Y及W-135群脑膜炎奈瑟菌多糖特异性抗体。
Clin Vaccine Immunol. 2009 Mar;16(3):433-6. doi: 10.1128/CVI.00364-08. Epub 2009 Jan 7.
4
Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands.荷兰无脾或脾功能不全患者的疫苗接种覆盖率及对感染风险的认知情况
Vaccine. 2008 Dec 9;26(52):6975-9. doi: 10.1016/j.vaccine.2008.09.052. Epub 2008 Oct 9.
5
Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides.开发一种基于荧光珠的多重免疫测定法,以确定针对A群和C群脑膜炎奈瑟菌多糖的免疫球蛋白G亚类反应。
Clin Vaccine Immunol. 2008 Aug;15(8):1188-93. doi: 10.1128/CVI.00478-07. Epub 2008 Jun 11.
6
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.在人类婴儿中,使用蛋白质 - 多糖结合疫苗进行初次免疫期间抗体和记忆B细胞反应的强度与抗体的持久性及加强免疫反应的强度相关。
J Immunol. 2008 Feb 15;180(4):2165-73. doi: 10.4049/jimmunol.180.4.2165.
7
Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.对先前已接种多糖疫苗的无脾儿童进行肺炎球菌多糖疫苗或结合疫苗的随机再接种。
Vaccine. 2007 Jul 20;25(29):5278-82. doi: 10.1016/j.vaccine.2007.05.014. Epub 2007 Jun 4.
8
Antibody responses to pneumococcal and hemophilus vaccinations in splenectomized patients with hematological malignancies or trauma.脾切除的血液系统恶性肿瘤患者或创伤患者对肺炎球菌和嗜血杆菌疫苗的抗体反应。
Wien Klin Wochenschr. 2007;119(7-8):228-34. doi: 10.1007/s00508-006-0752-5.
9
Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.通过抑制和离液剂酶联免疫吸附测定法测量的针对脑膜炎奈瑟菌C群多糖结合疫苗的免疫球蛋白G反应的亲和力。
Clin Vaccine Immunol. 2007 Apr;14(4):397-403. doi: 10.1128/CVI.00241-06. Epub 2007 Feb 7.
10
Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis.脑膜炎球菌C疫苗在青少年特发性关节炎中的安全性和有效性。
Arthritis Rheum. 2007 Feb;56(2):639-46. doi: 10.1002/art.22399.